Clinical Trial Update: Assessing a Risk Model for G6PD Deficiency [Phase 4]

View source ↗

Summary

Phase 4 trial assessing a risk model for glucose-6-phosphate dehydrogenase (G6PD) deficiency related to malaria; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• G6pd Deficiency
• Malaria

Snippet

Sponsor: PATH | Conditions: Malaria, Vivax, G6PD Deficiency | Phase 4 | Status: TERMINATED | Results posted: 2021-11-12